同源康医药-B年度亏损3.88亿元 现金储备4.60亿元

格隆汇资讯
27 Mar

格隆汇3月27日丨同源康医药-B(02410.HK)公布年度业绩,集团的收入从截至2023年12月31日止年度的人民币0元增加至截至2024年12月31日止年度的人民币10.7万元,主要是研发服务收入增加所致。整体毛利从截至2023年12月31日止年度的人民币0元增加至截至2024年12月31日止年度的人民币14,000元,毛利率为13.1%。报告期间的亏损由截至2023年12月31日止年度的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10